Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Nifelat 10 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Yellow, round, scored, film-coated tablets with Remedica’s logo on one side. The tablet can be divided into equal doses using a pill cutter. |
Each film-coated tablet contains 10 mg nifedipine.
Excipient(s) with known effect: This product contains 60,9 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nifedipine |
Nifedipine is a calcium antagonist of the 1,4-dihydropyridine type. Calcium antagonists reduce the transmembranal influx of calcium ions through the slow calcium channel into the cell. As a specific and potent calcium antagonist, nifedipine acts particularly on the cells of the myocardium and the smooth muscle cells of the coronary arteries and the peripheral resistance vessels. The main action of nifedipine is to relax arterial smooth muscle, both in the coronary and peripheral circulation. Nifedipine Tablets are formulated to achieve controlled delivery of nifedipine in a release profile sufficient to enable once-daily administration to be effective in clinical use. |
| List of Excipients |
|---|
|
Core: Povidone Coating: Hypromellose |
PVC/Aluminium blisters. Pack sizes of 30, 100 and 1000 film-coated tablets.
PP/PE containers with PE closure. Pack sizes of 100 and 1000 film-coated tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
19905
Date of first authorization: 29 December 2005
Date of latest renewal: 10 July 2013
| Drug | Countries | |
|---|---|---|
| NIFELAT | Albania, Cyprus, Hong Kong, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
